- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Novartis Pharmaceuticals
Total 21474 results
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedA Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsSolid TumorsSpain, Italy, United States, Canada
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML)Japan
-
Novartis PharmaceuticalsCompletedPancreatic CancerSpain, United Kingdom, United States
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | MesotheliomaUnited States, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsJapan
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
Novartis PharmaceuticalsTerminatedProstate Cancer | Bone MetastasesUnited States
-
Novartis PharmaceuticalsTerminatedNeovascular Age-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Germany, Spain, Singapore
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Novartis PharmaceuticalsCompletedKidney TransplantationFrance, Germany, United Kingdom, Spain, Switzerland, United States, Canada, Italy
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedNon Familial Chylocmicronemia Syndrome (Non-FCS)United States, Canada, Russian Federation
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
Novartis PharmaceuticalsCompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Greece, Canada, Finland, Italy, Spain, United Kingdom, France, Denmark, South Africa, Australia, Poland
-
Novartis PharmaceuticalsCompletedBreast Cancer | Hematologic NeoplasmsNetherlands, Switzerland, United Kingdom, United States
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Novartis PharmaceuticalsCompletedType II Diabetes Mellitus | Congestive Heart FailureRussian Federation, Singapore, Italy, Czechia, Lithuania, Germany, Guatemala, India, Denmark, Estonia, Slovakia, Romania, Latvia, Greece, Poland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedHematological MalignanciesGermany, Switzerland, France
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Gastric Cancer | Gastro-esophageal Junction CancerUnited States, France, Italy, Taiwan, United Kingdom, Turkey, Germany, Singapore, Australia, Russian Federation, Korea, Republic of, Switzerland, Netherlands, Canada
-
Novartis PharmaceuticalsCompletedGlioblastomaAustralia, Spain, Canada, United States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
Novartis PharmaceuticalsCompletedAdvanced or Recurrent Solid TumorsJapan
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited Kingdom, Germany
-
Novartis PharmaceuticalsCompletedBreast Cancer | Advanced Solid Tumors | Cowden SyndromeNetherlands, Spain, Germany, United Kingdom, United States
-
Novartis PharmaceuticalsTerminatedMetastatic Cancer With Impaired Renal Function | Metastatic Cancer With Normal Renal FunctionBelgium
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompletedRenal ImpairmentUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedNeoplasms, Breast Neoplasms, Head and Neck NeoplasmsUnited States, Spain, France, Italy
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompletedBreast Cancer | Ovarian Cancer | Colon Cancer | Endometrium CancerCanada, Netherlands, Spain, United States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentUnited States
-
Novartis PharmaceuticalsCompletedMild Moderate | or Severe Renal ImpairmentGermany
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentGermany, United States, Hungary
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
Novartis PharmaceuticalsCompletedFollicular LymphomaSpain, Belgium, Canada, Italy, Australia, United States, France